Liver-type Fatty Acid-binding Protein Attenuates Renal Injury Induced by Unilateral Ureteral Obstruction

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2006 Sep 28

PMID 17003471

Citations 36

Authors

Atsuko Kamijo-Ikemori

Takeshi Sugaya

Ayako Obama

Junya Hiroi

Hiroshi Miura

Minoru Watanabe

Toshio Kumai

Ritsuko Ohtani-Kaneko

Kazuaki Hirata

Kenjiro Kimura

Affiliations

Soon will be listed here.

Abstract

Liver-type fatty-acid-binding protein (L-FABP), which has high affinity for long-chain fatty acid oxidation products, may be an effective endogenous antioxidant. To examine the role of L-FABP in tubulointerstitial damage, we used a unilateral ureteral obstruction (UUO) model. We established human L-FABP (hL-FABP) gene transgenic (Tg) mice and compared the tubulointerstitial pathology of the Tg mice (n = 23) with that of the wild-type (WT) mice (n = 23). Mice were sacrificed on days 2, 4, 5, or 7 after UUO. Although mouse L-FABP was not expressed in WT mice, hL-FABP was expressed in the proximal tubules of the Tg mice with UUO (UUO-Tg) and in sham-operated Tg mice. The expression of renal hL-FABP was significantly increased in UUO-Tg compared with sham-operated Tg mice. The number of macrophages (F4/80) infiltrating the interstitium and the level of expression of MCP-1 and MCP-3 were significantly lower in UUO-Tg kidneys compared with UUO-WT kidneys. In UUO-Tg kidneys, the degree of the tubulointerstitial injury and the deposition of type I collagen were significantly lower than that of UUO-WT kidneys. On day 7, lipid peroxidation product accumulated in the UUO-WT kidneys but not in that of UUO-Tg kidneys. In conclusion, renal L-FABP may reduce the oxidative stress in the UUO model, ameliorating tubulointerstitial damage.

Citing Articles

Lipidomic study of kidney in a mouse model with urine flow obstruction.

Gowda D, Masum M, Gowda S, Shekhar C, Rubel M, Kira S Sci Rep. 2024; 14(1):18042.

PMID: 39098953 PMC: 11298537. DOI: 10.1038/s41598-024-68270-5.

Protein Biomarkers in Chronic Kidney Disease in Children-What Do We Know So Far?.

Rybi Szuminska A, Wasilewska A, Kamianowska M J Clin Med. 2023; 12(12).

PMID: 37373629 PMC: 10298870. DOI: 10.3390/jcm12123934.

Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury.

Yanishi M, Kinoshita H BMC Nephrol. 2022; 23(1):125.

PMID: 35361160 PMC: 8969288. DOI: 10.1186/s12882-022-02760-4.

Extracellular Vesicles in Redox Signaling and Metabolic Regulation in Chronic Kidney Disease.

Aparicio-Trejo O, Aranda-Rivera A, Osorio-Alonso H, Martinez-Klimova E, Sanchez-Lozada L, Pedraza-Chaverri J Antioxidants (Basel). 2022; 11(2).

PMID: 35204238 PMC: 8868440. DOI: 10.3390/antiox11020356.

Urinary FABP1 is a biomarker for impaired proximal tubular protein reabsorption and is synergistically enhanced by concurrent liver injury.

Kawakami R, Matsui M, Konno A, Kaneko R, Shrestha S, Shrestha S J Pathol. 2021; 255(4):362-373.

PMID: 34370295 PMC: 9292749. DOI: 10.1002/path.5775.

References

Martin G, Poirier H, Hennuyer N, CROMBIE D, Fruchart J, HEYMAN R . Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target. J Biol Chem. 2000; 275(17):12612-8. DOI: 10.1074/jbc.275.17.12612. View

de Haan J, Bladier C, Griffiths P, KELNER M, OShea R, Cheung N . Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem. 1998; 273(35):22528-36. DOI: 10.1074/jbc.273.35.22528. View

Wolfrum C, Ellinghaus P, Fobker M, Seedorf U, Assmann G, Borchers T . Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein. J Lipid Res. 1999; 40(4):708-14. View

Ou Z, Natori Y . Gene expression of CC chemokines in experimental acute tubulointerstitial nephritis. J Lab Clin Med. 1999; 133(1):41-7. DOI: 10.1053/lc.1999.v133.a94726. View

Kawada N, Moriyama T, Ando A, Fukunaga M, Miyata T, Kurokawa K . Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 1999; 56(3):1004-13. DOI: 10.1046/j.1523-1755.1999.00612.x. View

Pat B, Yang T, Kong C, Watters D, Johnson D, Gobe G . Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int. 2005; 67(3):931-43. DOI: 10.1111/j.1523-1755.2005.00157.x. View

Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu T . Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial. J Lab Clin Med. 2005; 145(3):125-33. DOI: 10.1016/j.lab.2004.12.003. View

Bascands J, Schanstra J . Obstructive nephropathy: insights from genetically engineered animals. Kidney Int. 2005; 68(3):925-37. PMC: 1885837. DOI: 10.1111/j.1523-1755.2005.00486.x. View

Wang G, Gong Y, Anderson J, Sun D, Minuk G, Roberts M . Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology. 2005; 42(4):871-9. DOI: 10.1002/hep.20857. View

10.

Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y . Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol. 2001; 12(2):317-325. DOI: 10.1681/ASN.V122317. View

11.

Wolfrum C, Borrmann C, Borchers T, Spener F . Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci U S A. 2001; 98(5):2323-8. PMC: 30137. DOI: 10.1073/pnas.051619898. View

12.

Zhang F, Hamilton J . Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. implications for transmembrane and intracellular transport and for protection from lipid peroxidation. J Biol Chem. 2001; 276(19):15575-80. DOI: 10.1074/jbc.M011623200. View

13.

Zimmerman A, Veerkamp J . Fatty-acid-binding proteins do not protect against induced cytotoxicity in a kidney cell model. Biochem J. 2001; 360(Pt 1):159-65. PMC: 1222213. DOI: 10.1042/0264-6021:3600159. View

14.

Ohashi R, Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y . Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol. 2002; 13(7):1795-805. DOI: 10.1097/01.asn.0000018408.51388.57. View

15.

Huang H, Starodub O, McIntosh A, Kier A, Schroeder F . Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells. J Biol Chem. 2002; 277(32):29139-51. DOI: 10.1074/jbc.M202923200. View

16.

Yang J, Dai C, Liu Y . Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol. 2002; 13(10):2464-77. DOI: 10.1097/01.asn.0000031827.16102.c1. View

17.

Klahr S, Morrissey J . Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol. 2002; 283(5):F861-75. DOI: 10.1152/ajprenal.00362.2001. View

18.

Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T . Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int. 2002; 62(5):1628-37. DOI: 10.1046/j.1523-1755.2002.00618.x. View

19.

Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H . Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol. 2003; 14(4):1066-71. DOI: 10.1097/01.asn.0000059339.14780.e4. View

20.

Shimizu H, Maruyama S, Yuzawa Y, Kato T, Miki Y, Suzuki S . Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephrol. 2003; 14(6):1496-505. DOI: 10.1097/01.asn.0000069223.98703.8e. View